Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Noxafil“
Suchtreffer
Begriffe & Kennungen
Noxafil · 4.3 · Co-administration with the CYP3A4 substrates terfenadine, astemizole, cisapride, pimozide, halofantrine or qui
Eintrag öffnenNoxafil · 4.3 · Co-administration with the CYP3A4 substrates terfenadine, astemizole, cisapride, pimozide, halofantrine or qui
Eintrag öffnenNoxafil · 4.3 · Co-administration with the HMG-CoA reductase inhibitors simvastatin, lovastatin and atorvastatin (see section
Eintrag öffnenNoxafil · 4.3 · Co-administration with the HMG-CoA reductase inhibitors simvastatin, lovastatin and atorvastatin (see section
Eintrag öffnenNoxafil · 4.3 · Co-administration with the HMG-CoA reductase inhibitors simvastatin, lovastatin and atorvastatin (see section
Eintrag öffnenNoxafil · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenNoxafil · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenNoxafil · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenNoxafil · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenNoxafil · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenNoxafil · 4.4 Special warnings and precautions for use · 2
Eintrag öffnenNoxafil · 4.4 Special warnings and precautions for use · 3
Eintrag öffnenNoxafil · 4.4 Special warnings and precautions for use · 4
Eintrag öffnenNoxafil · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenNoxafil · 4.5 Interaction with other medicinal products and other forms of interaction · 2
Eintrag öffnenNoxafil · 4.5 Interaction with other medicinal products and other forms of interaction · 3
Eintrag öffnenNoxafil · 4.5 Interaction with other medicinal products and other forms of interaction · 4
Eintrag öffnenNoxafil · 4.5 · 24 the CYP3A4 substrate may need to be reduced. If posaconazole is used concomitantly with CYP3A4 substrates t
Eintrag öffnenNoxafil · 4.5 · 25 reserve azole antifungals, including posaconazole, for patients receiving a vinca alkaloid, including vincr
Eintrag öffnenNoxafil · 4.5 · 26 related to antiretroviral agents that are substrates of CYP3A4 is recommended during co- administration wit
Eintrag öffnen